Objectives-To assess the size of the elderly population for whom influenza vaccine is indicated and how many are vaccinated.
Introduction
Each autumn the chief medical officer issues guidance on the use of influenza vaccine in the United Kingdom. Immunisation is recommended for elderly people living in residential homes and long stay hospitals and people, especially the elderly, who have chronic heart, lung, or renal disease; diabetes and other less common endocrine disorders; and immunosuppression due to disease or treatment.' The outbreak of influenza A in 1989-90 was the worst in England and Wales since 1976 and may have been responsible for about 26000 deaths.2 The scale of the epidemic and number of deaths raised the question whether immunisation should be extended to include all people over the age of 65 .
Review of deaths during the epidemic showed that it was very elderly people, especially those in residential accommodation and with chronic medical conditions, who were most susceptible.3 Moreover data obtained before and during the epidemic suggested that vaccine coverage of elderly people and those with heart and lung disease was low. [4] [5] [6] The Department of Health influenza advisory committee suggested that more strenuous efforts should be made to immunise people in the recognised risk groups. This was thought to be more effective than targeting all elderly people, which by increasing general practitioners' workload might decrease coverage of those at greatest risk.
Although the total number of doses of influenza vaccine sold annually in the United Kingdom is known, comparatively few data are available about who receives it or the size of the priority groups for immunisation. I therefore examined the distribution of influenza vaccine among 800 elderly people living in their own homes in Leicestershire. The aims of the study were to establish the size of the elderly population for whom vaccine is indicated, how many were offered vaccine and received it, whether the people at risk who received vaccine differed from those who did not, whether the offer of vaccine was largely opportunistic or planned, acceptance rates, reasons for nonacceptance of vaccine, and how many people at lowrisk were immunised. BMJ voLuME 306 10 APRIL 1993 underlying chronic illness or that an intercurrent cold was a contraindication, six had problems of access to vaccine or their practice, six were unconvinced of the vaccine's efficacy, one was concerned about a possible drug interaction, and one forgot to seek immunisation. Another nine respondents gave a variety of reasons for not being immunised, including being away on holiday.
Patients and methods

Discussion
Most people certified as dying of influenza in the United Kingdom are aged 75 years or over.' Review of patients who died during the 1989-90 influenza outbreak showed that the impact was greatest in non-NHS hospitals, institutions that care for the sick, and other communal establishments.7 More detailed studies of the deaths from influenza in Leicestershire showed that 93% of patients had chronic medical conditions, the average age at death was 84 years, and 87% were aged 75 or over.3 Vaccine is recommended for elderly people living in residential care and those with certain medical conditions. But little is known about the effectiveness of the immunisation policy or whether deaths could be reduced by immunising all people over 65 or 75.
My data indicate that just over half the people aged 65 years or over living at home have one or more medical indication for immunisation. Because the survey was conducted by post elderly people with dementia or mobility problems may have been less likely to respond. However, the high response rate (76%) suggests that this is unlikely to have caused significant bias. The number of people with one or more diseases for which vaccination is recommended did not increase with age, and in view of the low mortality among ambulant people without such diseases38 my data do not support a policy of immunising all people aged over 65 or 75 years.
Emphasis should be given to improving immunisation rates among those at risk. Since a quarter of the offers ofvaccine were made to patients without medical indications, higher immunisation rates among people at risk could be achieved partly by diverting attention from those at lower risk. Fifty one of 164 (31-1%) immunised people did not fulfil departmental recommendations for immunisation.
IMPROVING TARGETING
Most people who were immunised had been offered vaccine opportunistically during consultations with a general practitioner or nurse. Only six (3-1%) were offered vaccine in writing or by a telephone call from the practice. Since vaccine was accepted by over three quarters of those offered it, increased vaccination of people at risk should be possible with appropriate targeting. This theory is strengthened by the finding that the principal reasons given by patients for not being immunised were not realising they were at risk and lack of advice or recommendations from practitioners. Age, sex, and disease registers could readily be used to identify people who should be immunised and since more than 95% of elderly people with medical conditions for vaccine were prescribed drugs by their practitioner, attendance for repeat prescriptions could be used to offer advice or an appointment with the practice nurse for immunisation.
Practitioners should identify the reasons why their high risk patients are not being immunised. In this study 13% did not want vaccine and several of these stated that they would prefer to let nature take its course. Other reasons included misconceptions about the vaccine, and about 5% were concemed by side effects. Until the late 1960s local and systemic adverse reactions to influenza vaccines were common and at times severe 
